Aurora Spine Corporation: First Surgical Implant of ZIP MIS Interspinous Implant Performed in Germany
19 Diciembre 2013 - 8:01AM
Marketwired
Aurora Spine Corporation: First Surgical Implant of ZIP MIS
Interspinous Implant Performed in Germany
CARLSBAD, CALIFORNIA--(Marketwired - Dec 19, 2013) - Aurora
Spine Corporation (TSX-VENTURE:ASG) announced today the first
surgical implant of the company's ZIP ULTRA™ Minimally Invasive
Interspinous Implant in Germany. The surgery was performed at
Kliniken des landkreises lorrach in Southwest Germany by Professor
Pfieffer.
This surgery marks the expansion of the use of Aurora's MIS
device into another country, thereby strengthening the growth of
Aurora Spine worldwide. The company works to continuously innovate
in order to provide surgeons with the efficiency, simplicity and
security they desire during minimally invasive procedures.
"It has been our honor to work with Dr. Pfeiffer, Dr. Rozeik,
and their teams. Through our collaboration, the first ZIP ULTRA MIS
Interspinous Fusion system surgeries in Germany have been
completed," stated Laszlo Garamszegi, Chief Technical Officer of
the company. "We are excited to continue to extend the reach of the
ZIP MIS Interspinous Fusion system beyond previous locations. We
believe that this new fusion technology will allow patients to
rapidly resume their normal routines."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new
solutions to the spinal implant market through a series of
innovative, minimally invasive, regenerative spinal implant
technologies.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking
Information" in Aurora Spine's final prospectus (collectively,
"forward-looking information"). Forward-looking information in this
news release includes information concerning the growth potential
of Aurora Spine's products and the introduction, potential and use
of its products in new markets. Aurora Spine cautions investors of
its securities about important factors that could cause Aurora
Spine's actual results to differ materially from those projected in
any forward-looking statements included in this news release. Any
statements that express, or involve discussions as to,
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Aurora Spine CorporationTrent NorthcuttPresident and Chief
Executive Officer(760) 424-2004Aurora Spine CorporationEric
FronkChief Financial Officer(760) 424-2004
Aurora Spine (TSXV:ASG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Aurora Spine (TSXV:ASG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024